Multidrug therapy cost: a hypothetical analysis
نویسندگان
چکیده
منابع مشابه
Cost-effectiveness of hypothetical new cancer drugs
Background: In the last decade, a number of new treatment modalities have been developed for patients with small cell lung cancer (SCLC). The clinical effects are encouraging, but little is known about the costs and cost-effectiveness of new drugs. Methods: A Markov chain model has been developed to project patient outcomes and costs for patients with advanced SCLC. All patients in the control ...
متن کاملEpidemiological and cost analysis of multidrug-resistant tuberculosis in Oman.
We conducted an epidemiological and cost analysis for all 13 patients diagnosed with multaidrug-resistant tuberculosis (11 pulmonary, 2 extrapulmonary) in Oman from January 2000 to October 2005. The disease was secondary, or acquired, in 12 of 13 patients. A total of 140 contacts were screened (mean 10.8 persons per patient), but contact tracing revealed no secondary cases. The mean number of d...
متن کاملA Hypothetical Reasoning Algorithm for Linguistic Analysis
The Lambek calculus, an intuitionistic fragment of Linear Logic, has recently been rediscovered by linguists. Due to its built-in hypothetical reasoning mechanism, it allows for describing a certain range of those phenomena in natural language syntax which involve incomplete subphrases or moved constituents. Previously, it seemed unclear how to extent traditional parsing techniques in order to ...
متن کاملGlaucoma Therapy: Prescribing Pattern and Cost Analysis
In the present study out of total 200 prescriptions of POAG (primary open angle glaucoma) studied 66% were found to be of monotherapy including timolol, brimonidine, pilocarpine, betaxolol, levobunolol, latanoprost and apraclonidine in 30%, 15 %, 6%, 8% , 4%, 1% and 2% of the prescriptions respectively and 34% were found to be of polypharmacy with timolol+pilocarpine, timolol+acetazolamide, tim...
متن کاملNutrition therapy cost analysis in the US
BACKGROUND Bloodstream infections (BSI) occur in up to 350 000 inpatient admissions each year in the US, with BSI rates among patients receiving parenteral nutrition (PN) varying from 1.3% to 39%. BSI-attributable costs were estimated to approximate $US12 000 per episode in 2000. While previous studies have compared the cost of different PN preparation methods, this analysis evaluates both the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Leprosy Review
سال: 1986
ISSN: 0305-7518
DOI: 10.5935/0305-7518.19860119